Povidone-iodine (PVP-I) is one of the most widely used antiseptics in the world, applied across settings ranging from operating rooms and emergency departments to eye clinics and dairy farms. It works by slowly releasing molecular iodine, which kills bacteria, viruses, and fungi on contact. What makes PVP-I unusual among antiseptics is its broad spectrum combined with a notable absence of documented bacterial resistance, even after decades of use. But the picture is not entirely straightforward: concentration, exposure time, and the patient’s own physiology all shape whether PVP-I helps or harms.
How Povidone-Iodine Actually Works
The familiar brown liquid you see painted onto skin before surgery is not pure iodine. It is a complex of iodine bound to a polymer called polyvinylpyrrolidone, which acts as a carrier. In solution, PVP-I sets up an equilibrium between iodine molecules that are still bound to the polymer and free iodine molecules floating loose in the liquid.1PubMed Central. Dilute Povidone-Iodine Irrigation: The Science of Molecular Iodine (I2) Kinetics and Its Antimicrobial Activity That free iodine is the part that does the killing. It penetrates microbial cell walls and disrupts the proteins and structures inside. The polymer’s job is to act as a reservoir, steadily releasing iodine so the solution stays active over time rather than dumping its entire payload in a single burst.
This reservoir effect is why PVP-I maintains antimicrobial activity longer than a simple iodine tincture would. Paradoxically, diluting PVP-I can actually increase the amount of free iodine available in the short term, because dilution shifts the equilibrium toward releasing more iodine from the polymer. That quirk has practical consequences for choosing concentrations, as we’ll see below.
Surgical Skin Preparation
Before any incision, the surgeon’s team paints the patient’s skin with an antiseptic to reduce surgical site infections. PVP-I and chlorhexidine-alcohol are the two main options, and the debate over which one performs better has produced a large body of research with somewhat inconsistent results.
A widely cited trial from 2010 found that chlorhexidine-alcohol was clearly superior to aqueous povidone-iodine, with surgical site infections occurring in about 9.5% of the chlorhexidine group versus roughly 16% in the povidone-iodine group.2PubMed. Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis That result tilted many guidelines toward chlorhexidine. But an important detail often gets lost: that trial compared chlorhexidine dissolved in alcohol against povidone-iodine in water. Alcohol itself is a potent antiseptic, so the comparison was not quite apples to apples.
When both agents are dissolved in alcohol, the gap narrows considerably. A large 2024 randomized trial of cardiac and abdominal surgery patients found that povidone-iodine in alcohol was noninferior to chlorhexidine in alcohol, with infection rates of about 5.1% versus 5.5%.3JAMA. Povidone Iodine vs Chlorhexidine Gluconate in Alcohol for Preoperative Skin Antisepsis: A Randomized Clinical Trial An updated meta-analysis pooling data from over 29,000 patients across 32 studies still found a modest overall advantage for chlorhexidine, but the difference was relatively small.4PubMed Central. Chlorhexidine versus povidone-iodine for surgical site infection prevention: an updated meta-analysis and trial sequential analysis of randomized controlled trials In practice, both are considered acceptable choices, and PVP-I remains especially useful when chlorhexidine allergy is a concern or when the antiseptic will contact mucous membranes, where chlorhexidine can cause tissue damage.
Wound Care and Chronic Wounds
PVP-I has a long history in wound management, though its reputation in this area has gone through cycles of enthusiasm and skepticism. Earlier concerns centered on a real tension: iodine kills bacteria effectively but can also damage the body’s own cells involved in healing. The question has always been whether the antimicrobial benefit outweighs the cellular cost.
In chronic wounds such as venous leg ulcers, the evidence leans positive. One clinical study found that PVP-I dressings combined with compression bandages healed about 82% of ulcers, while the relapse rate for superficial skin infections was substantially lower with local PVP-I (about 11%) than with systemic antibiotics (about 32%).5PubMed. Quality control in chronic wound management: the role of local povidone-iodine (Betadine) therapy A review of the broader evidence concluded that PVP-I’s combination of antimicrobial breadth, biofilm-fighting ability, and tolerability positions it well for both acute and chronic wound treatment.6PubMed. Povidone iodine in wound healing: A review of current concepts and practices
One reason PVP-I earns particular interest in chronic wounds is biofilm. Bacteria in chronic wounds often form biofilms, sticky colonies encased in a protective matrix that makes them extremely difficult to kill with conventional antibiotics. PVP-I has shown potent anti-biofilm activity in laboratory tests. Against Pseudomonas aeruginosa biofilms, for example, PVP-I completely eradicated colonies of varying maturity, including seven-day-old biofilms, within three hours or less.7PubMed Central. Anti-biofilm Activity of Povidone-Iodine and Polyhexamethylene Biguanide: Evidence from In Vitro Tests Against mixed biofilms containing both MRSA and Candida (a fungus), full-strength PVP-I ointment achieved a greater than five-log reduction, essentially eliminating detectable organisms after four hours of contact.8PubMed Central. Povidone‐iodine ointment demonstrates in vitro efficacy against biofilm formation A review comparing antiseptic options for biofilm-colonized chronic wounds concluded that PVP-I had advantages over silver-based dressings and other antiseptics in terms of spectrum, tolerability, and the absence of resistance.9PubMed Central. Update on the role of antiseptics in the management of chronic wounds with critical colonisation and/or biofilm
The Concentration Tradeoff
Here is where PVP-I gets counterintuitive: stronger is not always better, and sometimes stronger is actively worse. At the concentrations used for skin prep (usually 5–10%), PVP-I is effective against microbes on intact skin. But when it contacts living tissue inside a wound, higher concentrations can harm the cells you actually need for healing.
Laboratory studies on human skin fibroblasts, the cells responsible for building new tissue, show that their growth is progressively slowed starting at concentrations as low as 0.01%, and completely stopped at 0.1% and above.10PubMed. Dilute povidone-iodine solutions inhibit human skin fibroblast growth More recent research found that at 0.2% PVP-I, fibroblast viability dropped by about a third, wound closure in the lab was cut in half, and cells showed signs of programmed cell death. At concentrations of 0.8% and higher, roughly 90% of cells died.11PubMed Central. Povidone Iodine Induced Apoptosis and Its Effect on Wound Healing in Human Dermal Fibroblasts
This is why clinicians increasingly use dilute PVP-I for wound irrigation and lavage, typically around 0.1–0.5%, where the solution retains meaningful antimicrobial activity while causing less collateral damage to healing tissue. One study in spine surgery found that wound irrigation with PVP-I diluted to 3% appeared effective at preventing surgical site infections, though the researchers noted the study was too small for definitive conclusions.12PubMed Central. Intraoperative Disinfection by Pulse Irrigation with Povidone-Iodine Solution in Spine Surgery The key takeaway for everyday use: PVP-I on intact skin before surgery can be full strength, but PVP-I inside an open wound should be diluted.
Eye Surgery
PVP-I plays a specific and well-established role in ophthalmology. Before cataract surgery and other procedures that enter the eye, a drop of dilute PVP-I is applied to the eye’s surface and surrounding skin to reduce the risk of endophthalmitis, a rare but devastating infection inside the eye. This practice has been standard since the 1980s.13PubMed. Povidone-iodine concentration and dosing in cataract surgery
The concentration matters here, too. A study comparing different strengths found that a single application of 5% PVP-I drops significantly reduced the bacterial load on the eye’s surface, while 1% PVP-I drops did not achieve a significant reduction.14PubMed Central. Effects of chloramphenicol, povidone-iodine 1% and 5% eye drops on the colonisation of conjunctival flora in patients undergoing cataract surgery The 5% concentration has become the standard in many surgical guidelines. The brief stinging sensation patients feel is generally well tolerated and resolves quickly.
The COVID Gargle Question
During the pandemic, PVP-I gargles, mouthwashes, and nasal sprays attracted enormous attention. The logic was straightforward: if PVP-I kills viruses on contact, could swishing it around your nose and throat reduce viral load and perhaps limit transmission?
In the lab, the results were genuinely impressive. PVP-I solutions at concentrations as low as 0.45% achieved greater than 99.99% viral kill against SARS-CoV-2 within 30 seconds.15PubMed Central. Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease PVP-I also shows activity against influenza, herpes simplex, adenovirus, and rhinovirus in test-tube studies.16PubMed. Virucidal activity and cytotoxicity of the liposomal formulation of povidone-iodine
But killing a virus on a plastic dish is very different from clearing it from living tissue inside a nose. Clinical trials were disappointing. A randomized trial found that PVP-I mouthwash, gargle, and nasal spray had no meaningful influence on how viral levels changed over time in COVID-19 patients.17JAMA Otolaryngology–Head & Neck Surgery. Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial A pilot study of 0.4% PVP-I nasal spray found poor virucidal activity in actual patients, with viral levels essentially unchanged from baseline four hours after application.18PubMed Central. A Pilot Study of 0.4% Povidone-Iodine Nasal Spray to Eradicate SARS-CoV-2 in the Nasopharynx The virus replicates within cells, not just on mucosal surfaces, so briefly rinsing the surface does not reach the main source of viral production. PVP-I gargles and sprays are unlikely to serve as meaningful prevention or treatment for respiratory infections, despite the compelling in vitro numbers.
Why Bacteria Have Not Developed Resistance
One of PVP-I’s most appealing features is something it has not done: generate resistant bacteria. After more than 50 years of clinical use, no documented resistance to PVP-I has emerged. This stands in contrast to chlorhexidine, the other mainstay antiseptic, to which resistance has been identified, and to mupirocin, a topical antibiotic whose resistance is a growing clinical problem.
Testing confirms this pattern holds in practice. A study of clinical Staphylococcus aureus isolates found zero PVP-I-resistant strains among the tested samples, while nearly half showed resistance to another common antiseptic.19PubMed Central. Effect of povidone-iodine and propanol-based mecetronium ethyl sulphate on antimicrobial resistance and virulence in Staphylococcus aureus PVP-I at 5% and 10% was also effective against strains that had already developed resistance to chlorhexidine and mupirocin.20PubMed Central. Povidone Iodine: Properties, Mechanisms of Action, and Role in Infection Control and Staphylococcus aureus Decolonization
The reason likely comes down to how iodine kills. Rather than targeting a single bacterial enzyme or pathway (which is how most antibiotics work, making it relatively easy for a mutation to dodge the drug), free iodine attacks multiple cellular targets simultaneously. It oxidizes proteins, disrupts membranes, and interferes with nucleic acids all at once. For a bacterium to develop resistance, it would need to simultaneously protect all of those targets, which is a much harder evolutionary trick.
Iodine Absorption and Your Thyroid
PVP-I is meant to work locally, on the skin or mucosal surface where you apply it. But iodine does get absorbed into the bloodstream, and that absorbed iodine can affect the thyroid gland, which uses iodine to make its hormones. For most healthy adults, this is a non-issue. But in certain populations and with extensive use, it can cause real problems.
Even through intact adult skin, iodine absorption can be substantial. A study of thyroid cancer patients who had their skin disinfected with PVP-I before surgery found that urinary iodine excretion (a measure of how much iodine entered the body) spiked to seven times its baseline level on the first postoperative day. The levels came back to normal within three to five days.21PubMed. Transcutaneous iodine absorption in adult patients with thyroid cancer disinfected with povidone-iodine at operation In orthopedic surgery patients who received PVP-I wound irrigation, urinary iodine levels were elevated for up to two weeks after surgery, though actual thyroid hormone levels did not change significantly.22PubMed Central. Systemic iodine levels increase with povidone-iodine irrigation, but does this affect thyroid functions? A case-control study
Where things can go wrong is with prolonged, extensive use on open wounds. A case report documented a patient who received weeks of PVP-I wound care for extensive burns and developed clinically significant hypothyroidism, with thyroid-stimulating hormone levels four times the upper limit of normal and depressed thyroid hormone levels. Urinary iodine levels exceeded 10,000 µg/L, indicating massive absorption.23PubMed Central. Povidone Iodine Disinfection Associated with Hypothyroidism and Potentially Contributing to Prolonged Kidney Failure This kind of scenario, large surface areas of damaged skin treated repeatedly with PVP-I over weeks, represents the highest-risk context for iodine overload.
Special Risks for Newborns
The population most vulnerable to PVP-I’s thyroid effects is premature and very-low-birthweight infants. Their skin is thinner and more permeable, their thyroid glands are immature, and even modest iodine loads can disrupt hormone production during a critical period of brain development.
A landmark study found that among very-low-birthweight infants exposed to iodine-containing antiseptics, 25% developed elevated thyroid-stimulating hormone levels within two weeks, compared with none in the unexposed control group. Their thyroid hormone levels dropped before the stimulating hormone rose, a pattern consistent with iodine overload suppressing the gland. Thyroid function did return to normal by the time the infants were discharged.24PubMed. Topical iodine-containing antiseptics and neonatal hypothyroidism in very-low-birthweight infants
Not all neonatal studies have found the same degree of harm. Another study evaluating routine neonatal intensive care unit procedures involving topical iodine found elevated urinary iodine but no documentation of primary hypothyroidism during the first ten days of life, suggesting that brief, limited skin applications may not cross the threshold into clinical thyroid dysfunction.25PubMed. Topical iodine and neonatal hypothyroidism The practical upshot is that many neonatal units have switched to chlorhexidine for skin antisepsis in premature infants, reserving PVP-I for situations where chlorhexidine is not appropriate. When PVP-I is used on a newborn, clinicians should minimize the amount applied and monitor thyroid function if exposure is prolonged.
True Allergy Is Rarer Than You Think
Many patients report an “iodine allergy,” and PVP-I is often avoided as a result. But true allergic contact dermatitis from PVP-I is uncommon. In a study that patch-tested 500 consecutive patients, about 2.8% initially tested positive. However, when those patients were retested with a more rigorous method to distinguish genuine allergy from simple skin irritation, only 2 out of 500 (0.4%) had confirmed allergic reactions.26PubMed. Allergic contact dermatitis from povidone-iodine: a re-evaluation study
It is also worth knowing that PVP-I allergy and shellfish allergy are not the same thing, despite persistent belief to the contrary. The iodine in shellfish is not what causes seafood allergies (those are triggered by specific proteins), and having a shellfish allergy does not predict a reaction to PVP-I. If you have experienced a genuine blistering or hive-producing reaction to PVP-I itself, that is a different matter, but a history of shellfish allergy alone is not a reason to avoid it.
Use in Livestock and Agriculture
PVP-I is not exclusively a human medical product. In dairy farming, iodine-based teat dips have been a standard tool for preventing mastitis, the udder infections that are one of the most common and costly problems in dairy herds. After milking, teat dips containing iodine are applied to seal and disinfect the teat canal before bacteria can enter.
Testing of iodine-based dipping agents against mastitis-causing bacteria showed reduction rates above 90%, with some organisms like Listeria monocytogenes reduced by more than 99.6%.27Annals of Agricultural and Environmental Medicine. Comparison of the effectiveness of dipping agents on bacteria causing mastitis in cattle Interestingly, the concentration question arises here too. A study comparing iodine teat dips found that the lowest concentration tested (0.1%) actually resulted in the fewest new infections, while the highest concentration (1%) was associated with the most, including the most clinical mastitis cases.28PubMed. Comparison of teat dips with differing iodine concentrations in prevention of mastitis infection The pattern mirrors what is seen in human wound care: more concentrated does not automatically mean more effective, and may mean more tissue irritation that paradoxically undermines the goal.
When PVP-I Is the Wrong Choice
For all its versatility, there are clear situations where PVP-I should be avoided or used with caution. Pregnant women should minimize exposure, particularly around delivery, because the fetal thyroid is sensitive to iodine excess. People with known thyroid disorders, especially Graves’ disease or Hashimoto’s thyroiditis, can experience thyroid flares from iodine loading. Anyone scheduled for radioactive iodine therapy or thyroid scintigraphy should avoid PVP-I for days to weeks beforehand, because absorbed iodine interferes with the imaging and treatment.21PubMed. Transcutaneous iodine absorption in adult patients with thyroid cancer disinfected with povidone-iodine at operation
PVP-I should also not be used to pack deep cavities or left in prolonged contact with large areas of open tissue without good reason. The risk of systemic iodine absorption scales with the surface area exposed, the duration of contact, and the degree of tissue damage. Short applications on intact skin are generally a non-issue for most adults. Extended use on burns or large open wounds is where monitoring becomes important. And despite being sold over the counter for minor cuts, full-strength PVP-I solution (10%) is more than most shallow home wounds need. A diluted solution or a PVP-I-impregnated dressing causes less collateral damage to the healing tissue while still addressing bacterial contamination.